Please try another search
Wednesday, November 8, 2017Just as late-market traders on Wall Street left work satisfied they’d sold Snap Inc. (NYSE:SNAP) stock following disappointing Q3 sales results in the app...
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) reported a loss of 14 cents per share in third-quarter 2017, narrower than the Zacks Consensus Estimate of a loss of 21 cents. The company had reported...
Model N, Inc. (NYSE:MODN) reported fiscal fourth-quarter 2017 adjusted loss of 6 cents per share, narrower than the year-ago quarter loss of 28 cents per share. The figure was also narrower than...
Celldex Therapeutics, Inc. (NASDAQ:CLDX) incurred third-quarter 2017 loss (adjusted for one-time items) of 14 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 24...
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported a third-quarter 2017 adjusted loss of 2 cents per share (excluding loss due to change in fair value of warrant liability), narrower than the Zacks...
Fidelity Advisor Emerging Asia C Fund FERCX seeks to provide growth of capital in the long run. FERCX invests the lion’s share of its assets in securities of companies from the emerging markets...
MGM Resorts International (NYSE:MGM) posted adjusted earnings of 33 cents per share, which came in line with the Zacks Consensus Estimate. However, the bottom-line declined 43.1% on a year-over-year...
Snap Inc. (NYSE:SNAP) reported loss per share of 14 cents, in line with the Zacks Consensus Estimate but wider than the year-ago quarter’s loss of 13 cents.The company reported revenues of...
Mercadolibre, Inc. (NASDAQ:MELI) reported mixed third-quarter 2017 results.Adjusted earnings of 63 cents missed the Zacks Consensus Estimate by 5 cents. Earnings were up 3.3% sequentially but down...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a loss of 86 cents per share in the third quarter of 2017, wider than the year-ago loss of 51 cents. The Zacks Consensus Estimate was pegged at a...
Shares of Avis Budget Group, Inc. (NASDAQ:CAR) fell 15.1% after reporting third-quarter revenues of $2,752 million, missing the Zacks Consensus Estimate of $2,776 millionValeant Pharmaceuticals...
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...
Benchmarks closed mixed on Tuesday with the Dow finishing at new highs and the S&P 500 and the Nasdaq ending in the red. Weak profit forecasts from both Priceline and TripAdvisor pulled the...
Mack-Cali Realty Corp. (NYSE:CLI) reported third-quarter 2017 core funds from operations (FFO) per share of 57 cents, missing the Zacks Consensus Estimate by a penny. However, the figure compared...
Humana Inc.’s (NYSE:HUM) third-quarter 2017 operating earnings per share of $3.39 beat the Zacks Consensus Estimate by approximately 3.7%. The bottom line improved 6.6% year over year driven...